Surprise Castle
The Pharmagellan Guide to Biotech Forecasting and Valuation

The Pharmagellan Guide to Biotech Forecasting and Valuation - Paperback

$91.99
$99.00
-7%
Quantity
01

Pay over time for orders over $35.00 with

Availability:In StockContributor:Frank S. David, Seth Robey, Andrew MatthewsPublish date:2017-01-06Pages:138
Language:EnglishPublisher:Pharmagellan, LLCISBN-13:9780998407500ISBN-10:099840750XUPC:9780998407500Book Category:Business & EconomicsBook Subcategory:Forecasting, Corporate Finance, IndustriesBook Topic:Valuation, Pharmaceutical & BiotechnologySize:9.00 x 6.00 x 0.32 inchesWeight:0.4696Product ID:SC1Z0Q4R7S

If you're a biotech executive, investor, deal maker, entrepreneur, or adviser--or aspire to be one--then you need to know how to build and analyze forecasts and valuation models of R&D-stage drugs.

THE PHARMAGELLAN GUIDE TO BIOTECH FORECASTING AND VALUATION is a comprehensive, thoroughly referenced handbook to creating and interpreting financial models for early-stage biopharma assets and companies.


- Vetted benchmarks for key drivers of income, expenses, and valuation.
- Proprietary analyses by Pharmagellan's experienced consulting team.
- More than 150 current references from peer-reviewed research, industry white papers, and SEC filings.

Whether you're making investment decisions, pitching to potential partners or funders, or assessing your own R&D program, this is the one-stop guide you need by your side.


Language:EnglishPublisher:Pharmagellan, LLCISBN-13:9780998407500ISBN-10:099840750XUPC:9780998407500Book Category:Business & EconomicsBook Subcategory:Forecasting, Corporate Finance, IndustriesBook Topic:Valuation, Pharmaceutical & BiotechnologySize:9.00 x 6.00 x 0.32 inchesWeight:0.4696Product ID:SC1Z0Q4R7S
Publisher: Pharmagellan, LLC

Free shipping on orders over $75. Standard shipping takes 3-7 business days. Returns accepted within 30 days of purchase.

Recently Viewed

View All